Past briefings

Wednesday, November 18, 2026

The top medical stories of the day, as they ran.

Morning edition

15 stories

  1. 1U.S. loses measles elimination status after 12 months of transmissionInfectious disease · 17 outlets
  2. 2White House withdraws Heidi Overton’s nomination to lead the FDADrugs and FDA · 9 outlets
  3. 3FDA approves Roche’s giredestrant combination for ESR1-mutated breast cancerDrugs and FDA · 4 outlets
  4. 4HHS finalizes HIPAA rule to speed patients’ access to health recordsHealth policy · 4 outlets
  5. 5AR1001 slowed Alzheimer’s decline in one trial group but not overallResearch · 3 outlets
  6. 6Marrow raises $173 million to develop blood disorder drugsIndustry · 4 outlets
  7. 7FDA approves neladalkib for previously treated ALK-positive lung cancerDrugs and FDA · 3 outlets
  8. 8FDA approves Gazyva for adults with primary membranous nephropathyDrugs and FDA · 2 outlets
  9. 9Experts warn H5N1 cases may be missed in Washington outbreakInfectious disease · 1 outlet
  10. 10Cognito reports Alzheimer’s trial results and plans FDA approval bidMedical devices · 2 outlets
  11. 11Larbi recalls three Yellow Dock Root lots over possible Salmonella contaminationRecalls · 1 outlet
  12. 12John H. Powers III appointed director of NIH infectious disease instituteInfectious disease · 2 outlets
  13. 13ECDC urges action as antibiotic resistance spreadsPublic health · 2 outlets
  14. 14Study links beer and spirits with acute kidney injury, but not wineResearch · 2 outlets
  15. 15Teladoc offers employers an option to contribute to GLP-1 costsInsurance · 2 outlets

Evening edition

17 stories

  1. 1U.S. loses measles elimination status after year of continuous transmissionInfectious disease · 18 outlets
  2. 2White House withdraws Heidi Overton’s nomination to lead the FDADrugs and FDA · 13 outlets
  3. 3FDA approves adrabetadex for infantile-onset Niemann-Pick diseaseDrugs and FDA · 4 outlets
  4. 4FDA approves neladalkib for previously treated ALK-positive lung cancerDrugs and FDA · 3 outlets
  5. 5HHS finalizes HIPAA rule to speed patients’ access to health recordsHealth policy · 3 outlets
  6. 6Hospitals rush to patch Java flaw after CISA alertHospitals · 2 outlets
  7. 7FDA approves Roche’s giredestrant combination for ESR1-mutated breast cancerDrugs and FDA · 2 outlets
  8. 8FDA cites modest benefit and safety risks in rejecting Summit’s lung cancer drugDrugs and FDA · 3 outlets
  9. 9Hims & Hers launches five compounded peptide and longevity treatmentsDrugs and FDA · 3 outlets
  10. 10Diranersen showed continued benefit in Alzheimer’s trial extension at 2 yearsResearch · 2 outlets
  11. 11CMS proposes rule to combat fraud across federal health programsHealth policy · 2 outlets
  12. 12Marrow raises $173 million to develop blood disorder drugsIndustry · 3 outlets
  13. 13Sanders plans to push Medicare for All in next CongressMedicare and Medicaid · 2 outlets
  14. 14AR1001 slowed Alzheimer’s decline in one trial group but not overallResearch · 2 outlets
  15. 15Teladoc offers employers an option to contribute to GLP-1 costsInsurance · 2 outlets
  16. 16Study finds AI-generated discharge summaries rated above clinician-written versionsResearch · 2 outlets
  17. 17GMC mistakenly sent complaint details about 223 doctors to newspaperHealth policy · 2 outlets

This Week in Medicine

This Week in Medicine

The week’s top stories, the recalls worth knowing, and a moment from medical history. Every Sunday.

Free. No spam. Unsubscribe anytime.